Loading...
Donor killer-cell immunoglobulin-like receptor (KIR) genotype does not improve graft-versus-leukemia responses in chronic lymphocytic leukemia (CLL) after unrelated donor transplant: a CIBMTR analysis
Allogeneic hematopoietic cell transplantation (alloHCT) remains the sole curative therapy for patients with CLL leading to 40–45% long-term survival. The impact of donor KIR genotype on outcomes of unrelated donor (URD) alloHCT for CLL is unknown. METHODS: We examined 573 adult (URD)-CLL recipient p...
Na minha lista:
| Udgivet i: | Biol Blood Marrow Transplant |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6511301/ https://ncbi.nlm.nih.gov/pubmed/30594542 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2018.12.763 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|